Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

Current Diabetes Reports

Volumn 5, Issue 1, 2005, Pages 24-29

  Muhs, Bart E ^b   Gagne, Paul ^b   Sheehan, Peter ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; DACTINOMYCIN; DEXAMETHASONE; ESTRADIOL; PACLITAXEL; RAPAMYCIN; TACROLIMUS;

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE MARKER; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; GANGRENE; HISTORY; HUMAN; IMAGING SYSTEM; INTERMITTENT CLAUDICATION; LIMB DISEASE; LIMB ISCHEMIA; PAIN; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL DISABILITY; PHYSICAL EXAMINATION; PREVALENCE; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SAPHENOUS VEIN; SENSITIVITY ANALYSIS; STENOSIS; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT INDICATION; VEIN BYPASS;

EID: 14044254172     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0063-7     Document Type: Review

References (42)

1. Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic InterSociety Concensus (TASC). J Vasc Surg 2000, 31, (1 Pt 2):S1-S29.
2. Kannel WB: Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1:333-339.
3. Hirsch AT, Criqui MH, Treat-Jacobson D: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
4. Elhadd TA, Jung RT, Stonebridge PA, Belch JF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes Int 1999, 16:163-166.
5. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287:2570-2581.
6. Schneider DL, Sobel BE: Diabetes and Thrombosis. Edited by Johnstone M, Veves A. Totowa, NJ: Humana Press; 2001.
7. LoGerfo FW, Coffman JD: Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care N Engl J Med 1984, 311:1615-1619.
8. Dolan NC, Liu K, Criqui MH, et al.: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002, 25:113-120.
9. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee [no authors listed]. Lancet 1996, 348:1329-1339.
10. Weitz JI, Byrne J, Clagett GF, et al.: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996, 94:3026-3049.
11. American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26:3333-3341.
12. Teodorescu VJ, Chen C, Morrissey N, et al.: Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers. Am J Surg 2004, 187: 5S-80S.
13. Andros G, Harris RW, Dulawa LB, et al.: The need for arteriography in diabetic patients with gangrene and palpable foot pulses Arch Surg 1984, 119:1260-1263.
14. Caputo GM, Cavanagh PR, Ulbrecht JS, et al.: Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994, 331:854-860.
15. Pomposelli FB Jr, Jepsen SJ, Gibbons GW, et al.: Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 1990, 11: 45-751; discussion 751-752.
16. Akbari CM, Pomposelli FB Jr, Gibbons GW, et al.: Lower extremity revascularization in diabetes: late observations. Arch Surg 2000, 135:452-456.
17. Hamdan AD, Rayan SS, Hook SC, et al.: Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovascular Surg 2002, 36:59-63.
18. Akbari CM, LoGerfo FW: Diabetes and peripheral vascular disease. J Vasc Surg 1999, 30:373-384.
19. Faries PL, LoGerfo FW, Hook SC, et al.: The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease. Am J Surg 2001, 181:251-255.
20. Faries PL, Brophy D, LoGerfo FW, et al.: Combined iliac angioplasty and infrainguinal revascularization surgery are effective in diabetic patients with multilevel arterial disease. Ann Vasc Surg 2001, 15:67-72.
21. Ballotta E, Renon L, Toffano M, et al.: Patency and limb salvage rates after distal revascularization to unclampable calcified outflow arteries. J Vasc Surg 2004, 39:539-546.
22. Johnston KW, Rae M, Hogg-Johnston SA, et al.: 5-year results of a prospective study of percutaneous transluminal angioplasty Ann Surg 1987, 206:403-413.
23. Palmaz JC, Laborde JC, Rivera FJ, et al.: Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol 1992, 15: 91-297.
24. Bosch JL, Hunink MG: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997, 204:87-96.
25. Cambria RP, Faust G, Gusberg R, et al.: Percutaneous angioplasty for peripheral arterial occlusive disease. Correlates of clinical success. Arch Surg 1987, 122:283-287.
26. Jeans WD, Cole SE, Horrocks M, Baird RN: Angioplasty gives good results in critical lower limb ischaemia. A 5-year follow-up in patients with known ankle pressure and diabetic status having femoropopliteal dilations. Br J Radiol 1994, 67:123-128.
27. van der Zaag ES, Legemate DA, Prins MH, et al.: Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004, 28:132-137.
28. Lofberg AM, Karacagil S, Ljungman C, et al.: Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 2001, 34:114-121.
29. Gray BH, Sullivan TM, Childs MB, et al.: High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997, 25:74-83.
30. Saxon RR, Coffman JM, Gooding JM, et al.: Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003, 14:303-311.
31. Parsons RE, Suggs WD, Lee JJ, et al.: Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998, 28:1066-1071.
32. Bolia A, Brennan J, Bell PR: Recanalisation of femoropopliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989, 40:325.
33. Vraux H, Hammer F, Verhelst R, et al.: Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg 2000, 20:441-446.
34. Desgranges P, Boufi M, Lapeyre M, et al.: Subintimal angioplasty: feasible and durable. Eur J Vasc Endovasc Surg 2004, 28:138-141.
35. Reekers JA, Kromhout JG, Jacobs MJ: Percutaneous intentional extraluminal recanalisation of the femoropopliteal artery. Eur J Vasc Surg 1994, 8:723-728.
36. London NJ, Srinivasan R, Naylor AR, et al.: Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 1994, 8:148-155.
37. Bolia A: Percutaneous intentional extraluminal (subintimal) recanalization of crural arteries. Eur J Radiol 1998, 28:199-204.
38. Lipsitz EC, Ohki T, Veith FJ, et al.: Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg 2003, 37:386-391.
39. Duda SH, Poerner TC, Wiesinger B, et al.: Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 2003, 14:291-301.
40. Sousa JE, Costa MA, Abizaid AC, et al.: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001, 104:2007-2011.
41. Sousa JE, Costa MA, Abizaid A, et al.: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001, 103:192-195.
42. Duda SH, Pusich B, Richter G, et al.: Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002, 106:1505-1509.